DB14983InvestigationalSmall molecule
Cimlanod is under investigation in clinical trial NCT02819271 (A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers).
- Formula / weight
- C5H7NO4S · 177.17 g/mol (avg)
- Also known as
- BMS-986231
Resolves to
Compound
Structure
InChIKey
LIXKIXWSKOENAB-UHFFFAOYSA-NSMILESCC1=CC=C(O1)S(=O)(=O)NOWhat you can answer from here — as of April 23, 2025
Which companies are running trials of Cimlanod, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account